Cart
sales@molnova.com
Besifovir(b)
CAS No. 441785-25-7
Besifovir(b)( —— )
Catalog No. M20442 CAS No. 441785-25-7
Besifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 75 | In Stock |
|
| 5MG | 125 | In Stock |
|
| 10MG | 195 | In Stock |
|
| 25MG | 356 | In Stock |
|
| 50MG | 529 | In Stock |
|
| 100MG | 754 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBesifovir(b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBesifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
-
DescriptionBesifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number441785-25-7
-
Formula Weight299.22
-
Molecular FormulaC10H14N5O4P
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL?(835.51 mM)
-
SMILESNc1ncc2ncn(CC3(CC3)OCP(O)(O)=O)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mak L Y Seto W K Lai C L et al. Pharmacokinetic evaluation of besifovir for the treatment of HBV infection[J]. Expert Opinion on Drug Metabolism & Toxicology 2018 14(1):101-106.
molnova catalog
related products
-
HAP-12
HAP-12 is a small molecule HBV capsid assembly effector that inhibits HBV DNA replication with EC50 of 0.5 uM.
-
JNJ-632
JNJ-632 (JNJ632) is a novel potent HVV capsid assembly modulator and HBV replication inhibitor.
-
GLP-26
GLP-26 is a novel potent HBV capsid modulator that reduces secreted HBeAg in HepNTCPDL cells transfected with HBV wild type with EC50 of 0.7 uM.
